SUPPRESSION OF INFLAMMATORY EDEMA BY IBUPROFEN INVOLVING A MECHANISM INDEPENDENT OF CYCLOOXYGENASE INHIBITION

被引：19

作者：

RAMPART, M ^{[1
]}

WILLIAMS, TJ ^{[1
]}

机构：

[1] MRC,CLIN RES CTR,VASC BIOL SECT,WATFORD RD,HARROW HA1 3UJ,MIDDX,ENGLAND

来源：

BIOCHEMICAL PHARMACOLOGY | 1986年 / 35卷 / 04期

关键词：

D O I：

10.1016/0006-2952(86)90351-5

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：581 / 586

页数：6

共 30 条

[1]

ABRAMSON S, 1984, AM J MED, V15, P3

[2] 5, 8, 11, 14-EICOSATETRAYNOIC ACID (ETYA) INHIBITS BINDING OF N-FORMYL-METHIONYL-LEUCYL-PHENYLALANINE (FLMP) TO ITS RECEPTOR ON HUMAN-GRANULOCYTES - A NOTE OF CAUTION [J].

ATKINSON, JP ;

SIMCHOWITZ, L ;

MEHTA, J ;

STENSON, WF .

IMMUNOPHARMACOLOGY, 1982, 4 (01) :1-9

[3] INCREASE IN VASCULAR-PERMEABILITY INDUCED BY LEUKOTRIENE-B4 AND THE ROLE OF POLYMORPHONUCLEAR LEUKOCYTES [J].

BJORK, J ;

HEDQVIST, P ;

ARFORS, KE .

INFLAMMATION, 1982, 6 (02) :189-200

[4] ACTION OF NONSTEROIDAL, ANTI-INFLAMMATORY DRUGS ON HUMAN AND RAT PERIPHERAL LEUKOCYTE MIGRATION INVITRO [J].

BROWN, KA ;

COLLINS, AJ .

ANNALS OF THE RHEUMATIC DISEASES, 1977, 36 (03) :239-243

[5] EFFECT OF INDOMETHACIN ON THE BINDING OF THE CHEMOTACTIC PEPTIDE FORMYL-MET-LEU-PHE ON HUMAN POLYMORPHONUCLEAR LEUKOCYTES [J].

COST, H ;

GESPACH, C ;

ABITA, J .

FEBS LETTERS, 1981, 132 (01) :85-88

[6] RECEPTOR-DIRECTED INHIBITION OF CHEMOTACTIC FACTOR-INDUCED NEUTROPHIL HYPERACTIVITY BY PYRAZOLON DERIVATIVES - DEFINITION OF A CHEMOTACTIC PEPTIDE ANTAGONIST [J].

DAHINDEN, C ;

FEHR, J .

JOURNAL OF CLINICAL INVESTIGATION, 1980, 66 (05) :884-891

[7] IBUPROFEN INHIBITS GRANULOCYTE RESPONSES TO INFLAMMATORY MEDIATORS - A PROPOSED MECHANISM FOR REDUCTION OF EXPERIMENTAL MYOCARDIAL INFARCT SIZE [J].

FLYNN, PJ ;

BECKER, WK ;

VERCELLOTTI, GM ;

WEISDORF, DJ ;

CRADDOCK, PR ;

HAMMERSCHMIDT, DE ;

LILLEHEI, RC ;

JACOB, HS .

INFLAMMATION, 1984, 8 (01) :33-44

[8] LEUKOCYTES IN LUNG INJURY [J].

HAMMERSCHMIDT, DE .

CHEST, 1983, 83 (05) :S16-S20

[9]

ISSEKUTZ AC, 1984, LAB INVEST, V50, P605

[10]

ISSEKUTZ AC, 1980, CLIN EXP IMMUNOL, V41, P512

← 1 2 3 →